| SC 13D/A | 2017-04-20 | Novo A/S | CoLucid Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2017-03-02 | GAMCO INVESTORS, INC. ET AL | CoLucid Pharmaceuticals, Inc. | - | 0.0% | EDGAR |
| SC 13D/A | 2017-03-01 | LILLY ELI & CO | CoLucid Pharmaceuticals, Inc. | 100 | 100.0% | EDGAR |
| SC 13G | 2017-02-14 | FMR LLC | CoLucid Pharmaceuticals, Inc. | 1,322,127 | 6.9% | EDGAR |
| SC 13G/A | 2017-02-10 | PRICE T ROWE ASSOCIATES INC /MD/ | CoLucid Pharmaceuticals, Inc. | 527,214 | 2.7% | EDGAR |
| SC 13G/A | 2017-02-10 | Care Capital III LLC | CoLucid Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2017-02-07 | PRICE T ROWE ASSOCIATES INC /MD/ | CoLucid Pharmaceuticals, Inc. | 2,330,434 | 12.1% | EDGAR |
| SC 13D | 2017-02-02 | GAMCO INVESTORS, INC. ET AL | CoLucid Pharmaceuticals, Inc. | 713,175 | 3.7% | EDGAR |
| SC 13D | 2017-01-27 | LILLY ELI & CO | CoLucid Pharmaceuticals, Inc. | 54,683 | 35.0% | EDGAR |
| SC 13G | 2017-01-26 | Care Capital III LLC | CoLucid Pharmaceuticals, Inc. | 1,413,130 | 7.3% | EDGAR |
| SC 13G/A | 2017-01-09 | Domain Partners VI, L.P. | CoLucid Pharmaceuticals, Inc. | - | 0.0% | EDGAR |
| SC 13G/A | 2016-10-11 | PRICE T ROWE ASSOCIATES INC /MD/ | CoLucid Pharmaceuticals, Inc. | 2,486,274 | 13.3% | EDGAR |
| SC 13D/A | 2016-09-14 | Novo A/S | CoLucid Pharmaceuticals, Inc. | 3,156,563 | 17.0% | EDGAR |
| SC 13D/A | 2016-02-26 | PAPPAS CAPITAL, LLC | CoLucid Pharmaceuticals, Inc. | 1,871,049 | 12.3% | EDGAR |
| SC 13D | 2016-02-16 | PAPPAS CAPITAL, LLC | CoLucid Pharmaceuticals, Inc. | 1,871,049 | 12.3% | EDGAR |
| SC 13G | 2016-02-12 | PRICE T ROWE ASSOCIATES INC /MD/ | CoLucid Pharmaceuticals, Inc. | 1,347,895 | 8.8% | EDGAR |
| SC 13G | 2016-01-19 | Domain Partners VI, L.P. | CoLucid Pharmaceuticals, Inc. | 2,245,902 | 14.7% | EDGAR |
| SC 13D | 2015-05-13 | Novo A/S | CoLucid Pharmaceuticals, Inc. | 3,056,563 | 20.2% | EDGAR |